Munich \u2014 The issue price of Inno\u00adscripta shares was 120 euros, which was at the lower end of the targe\u00adted price range of 110 to 140 euros. Accor\u00adding to Inno\u00adscripta, a total of 1.82 million shares were sold. For the foun\u00adders, owners and board members Michael Hohe\u00adnes\u00adter and Alex\u00adan\u00adder Meyer, this means proceeds of 218 million euros. Mean\u00adwhile, the company itself will not receive any cash inflows from the IPO. <\/p>\n
The enter\u00adprise value was set at EUR 1.2 billion as part of the IPO.<\/p>\n
Compli\u00adance soft\u00adware in focus \u201cOur vision is to be the worl\u00add\u2019s leading provi\u00adder of R&D manage\u00adment solu\u00adti\u00adons and to trans\u00adform the way compa\u00adnies inno\u00advate and grow. We strive to create a world where breakth\u00adrough ideas are seam\u00adlessly brought to life through advan\u00adced tech\u00adno\u00adlogy and opti\u00admi\u00adzed proces\u00adses. By conti\u00adnuously impro\u00adving our plat\u00adform and expan\u00adding our reach, we aim to help compa\u00adnies and indus\u00adtries realize their full poten\u00adtial, drive progress and make a lasting impact on the world,\u201d the company said. <\/p>\n Inno\u00adscripta opera\u00adtes profitably The stock market plans were supported by Beren\u00adberg, Hauck Aufh\u00e4u\u00adser and M.M. Warburg<\/strong>.<\/p>\n www.innoscripta.com\/de<\/p>\n Second IPO on the OTC market Munich \u2014 The issue price of Inno\u00adscripta shares was 120 euros, which was at the lower end of the targe\u00adted price range of 110 to 140 euros. Accor\u00adding to Inno\u00adscripta, a total of 1.82 million shares were sold. For the foun\u00adders, owners and board members Michael Hohe\u00adnes\u00adter and Alex\u00adan\u00adder Meyer, this means proceeds of 218 [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":56203,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-56354","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"\n
\n<\/strong>
\n Inno\u00adscripta is a soft\u00adware company that specia\u00adli\u00adzes in cloud-based compli\u00adance soft\u00adware for rese\u00adarch and deve\u00adlo\u00adp\u00adment. The newco\u00admer to the stock market claims to be the market leader in this field and as such is \u201cactive in advi\u00adsing compa\u00adnies from various sectors on tax-rela\u00adted rese\u00adarch funding\u201d for the successful manage\u00adment and docu\u00admen\u00adta\u00adtion of their rese\u00adarch and deve\u00adlo\u00adp\u00adment projects. <\/p>\n
\n<\/strong>
\n Busi\u00adness has been going very well at Inno\u00adscripta recently. In 2024, the company gene\u00adra\u00adted reve\u00adnue of EUR 64.7 million, compared to reve\u00adnue of EUR 39.4 million in the previous year. Inno\u00adscripta is also profi\u00adta\u00adble<\/strong>: EBIT rose from 15.15 million euros in 2023 to 37.3 million euros in 2024. <\/p>\n
\n<\/strong>
\n Inno\u00adscripta is the second company within a few weeks to go public on the Frank\u00adfurt Stock Exch\u00adange in the \u201cScale\u201d OTC segment. Pfis\u00adterer had previously cele\u00adbra\u00adted its stock market debut and impres\u00adsed inves\u00adtors. The initial price was above the issue price, and the Pfis\u00adterer share has contin\u00adued to trade at this level ever since.<\/p>\n","protected":false},"excerpt":{"rendered":"